A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1886-1893

  Malonza, Isaac M ^a   Tyndall, Mark W ^c   Ndinya Achola, Jeckoniah O ^a   Maclean, Ian ^d   Omar, Siad ^b   MacDonald, Kelly S ^e   Perriens, Jos ^f   Orle, Karina ^g   Plummer, Francis A ^a,d   Ronald, Allan R ^d   Moses, Stephen ^d  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b Nairobi City Commission   (Kenya)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNAIDS   (Switzerland)

^g ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYPHILIS SEROLOGY; TREATMENT FAILURE; ULCUS MOLLE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHANCROID; CIPROFLOXACIN; DOUBLE-BLIND METHOD; ERYTHROMYCIN; FEMALE; HAEMOPHILUS DUCREYI; HERPES GENITALIS; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; SYPHILIS; TREATMENT OUTCOME; TREPONEMA PALLIDUM;

EID: 0032750930     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315133     Document Type: Article

References (36)

1. 1. Albritton WL. Biology of Haemophilus ducreyi. Microbiol Rev 1989;53: 377-89.
2. 2. Plummer F, D'Costa L, Nsanze H, Dylewski J, Karasira P, Ronald AR. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983;2:1293-5.
3. 3. Tyndall MW, Agoki E, Malisa W, Ndinya-Achola JO, Ronald AR, Plummer FA. Sexual behavior and perceived risk of AIDS among men in Kenya attending a clinic for sexually transmitted diseases. Clin Infect Dis 1994;19: 441-7.
4. 4. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1, risk factors for seroconversion in men. Lancet 1989;2.403-7.
5. 5. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type I. J Infect Dis 1991;163:233-9.
6. 6. Plourde PJ, Pépin J, Agoki E, et al. Incidence of human immunodeficiency virus type-1 (HIV-1) seroconversion in African women with genital ulcers. J Infect Dis 1994;170:313-7.
7. 7. Telzak E, Chiasson M, Bevier P, Stoneburner R, Castro K, Jaffe H. HIV-1 seroconversion in patients with and without genital ulcer disease. Ann Intern Med 1993;119:1181-6.
8. 8. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment for sexually transmitted diseases on HIV infection in rural Tanzania: a randomized controlled trial. Lancet 1995;346:530-6.
9. 9. Wasserheit J. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
10. 10. Aldridge KE, Cammarata C, Martin DH. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi. Antimicrob Agents Chemother 1992;36: 1639-43.
11. 11. Rutanarugsa A, Vorachit M, Polnikorn N, Jayanetra P. Drug resistance of Haemophilus ducreyi. Southeast Asian J Trop Med Public Health 1990; 21:185-93.
12. 12. Plourde PJ, D'Costa L, Agoki E, et al. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992;165:949-52.
13. 13. D'Souza P, Pandhi R, Khanna N, Rattan A, Misra R. A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin, and cotrimoxazole. Sex Transm Dis 1998;25:293-5.
14. 14. Report of a WHO Study Group. Management of patients with sexually transmitted diseases. Geneva: World Health Organization, 1991 (WHO Technical Series, 810).
15. 15. Bodhidatta L, Taylor D, Chitwarakorn A, Kuvanont K, Echeverria P. Evaluation of 500-and 1000-mg doses of ciprofloxacin for the treatment of chancroid. Antimicrob Agents Chemother 1988;32:723-5.
16. 16. Naamara W, Plummer FA, Greenblatt R, D'Costa LJ, Ndinya-Achola JO, Ronald AR. Treatment of chancroid with ciprofloxacin: a prospective, randomized clinical trial. Am J Med 1987;82(Suppl 4A):317-20.
17. 17. Traisupa A, Wongba C, Tesavibul P. Efficacy and safety of a single dose therapy of a 500-mg ciprofloxacin tablet in chancroid patients. Infection 1988;16(Suppl 1):S44-5.
18. 18. Tyndall MW, Agoki E, Plummer F, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex Transm Dis 1994;21:231-4.
19. 19. Martin DH, Sargent S, Wendel G, McCormack W, Spier N, Johnson R. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin Infect Dis 1995;21:409-14.
20. 20. Tyndall M, Malisa M, Plummer FA, Ombetti J, Ndinya-Achola JO, Ronald AR. Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993;167:469-71.
21. 21. Taylor D, Pitarangsi C, Echeverria P, Panikabutra K, Suvonge C. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis 1985;152:1002-6.
22. 22. Dangor Y, Ballard R, Exposto F, Fehler G, Miller S, Koornhof H. Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis 1990;17: 184-9.
23. 23. DiCarlo R, Martin D, The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997;25:292-8.
24. 24. Morse S, Trees D, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997;175:583-9.
25. 25. Roesel DJ, Gwanzura L, Mason PR, Joffe M, Katzenstein DA. Polymerase chain reaction detection of Haemophilus ducreyi DNA. Sex Transm Infect 1998;74:63-5.
26. 26. Orle KA, Gates CA, Martin DH, Boyd BA, Weiss JB. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol 1996;34: 49-54.
27. 27. MacDonald K, Cameron W, D'Costa L, Ndinya-Achola JO, Plummer FA, Ronald AR. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989;33:612-4.
28. 28. Davis RL, Koup JR, Williams-Warren J, Weber A, Smith AL. Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrob Agents Chemother 1985;28:74-7.
29. 29. Drusano GL. Infection in the intensive care unit: beta-lactamase mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing. Clin Infect Dis 1998;27(Suppl 1):S111-6.
30. 30. Ndinya-Achola JO, Kihara AN, Fisher LD, et al. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi. Int J STD AIDS 1996;7:201-5.
31. 31. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men. JAMA 1998;280:61-6.
32. 32. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999;179:16-24.
33. 33. Beyer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis 1998;178:243-6.
34. 34. Risbud A, Chan-Tack K, Gadkari D, et al. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis 1999;26:55-62.
35. 35. Johnson SR, Martin DH, Cammarata C, Morse SA. Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid. J Clin Microbiol 1995;33:1036-8.
36. 36. Morse S. Etiology of genital ulcer disease and its relationship to HIV infection. Sex Transm Dis 1999;26:63-5.